Literature DB >> 8862414

Cholesterol-depleted cells that are relatively permissive for Semliki Forest virus infection.

M T Marquardt1, M Kielian.   

Abstract

Semliki Forest virus (SFV), an enveloped alphavirus, Infects cells by endocytosis followed by low pH-triggered fusion of the virus and endocytic vesicle membranes. Progeny virus is released by budding from the cell plasma membrane. In vitro, SFV fusion with artificial liposomes is triggered by low pH and is dependent on the presence of cholesterol and sphingolipid in the target liposome membrane. In tissue culture, both SFV fusion and virus exit are strongly cholesterol-dependent when assayed in cholesterol-depleted insect cells. We here describe the preparation of insect cells that while not containing detectable amounts of cholesterol, have adapted to sterol-depleted conditions, resulting in a more permissive phenotype for SFV infection. Although still less efficient at supporting SFV infection than control cholesterol-containing cells, the adapted cells show a 45-fold increase in primary infection by SFV, increased release of progeny virus, and enhanced virus growth kinetics compared to nonadapted cholesterol-depleted cells. The adapted cells are also about 85-fold more permissive for low pH-induced fusion of SFV with the plasma membrane, suggesting that adaptation correlates with a change in the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862414     DOI: 10.1006/viro.1996.0521

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Semliki forest virus budding: assay, mechanisms, and cholesterol requirement.

Authors:  Y E Lu; M Kielian
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Densovirus crosses the insect midgut by transcytosis and disturbs the epithelial barrier function.

Authors:  Y Wang; A S Gosselin Grenet; I Castelli; G Cermenati; M Ravallec; L Fiandra; S Debaisieux; C Multeau; N Lautredou; T Dupressoir; Y Li; M Casartelli; M Ogliastro
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Biochemical consequences of a mutation that controls the cholesterol dependence of Semliki Forest virus fusion.

Authors:  P K Chatterjee; M Vashishtha; M Kielian
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains.

Authors:  Anna Ahn; Don L Gibbons; Margaret Kielian
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Novel mutations that control the sphingolipid and cholesterol dependence of the Semliki Forest virus fusion protein.

Authors:  Prodyot K Chatterjee; Christina H Eng; Margaret Kielian
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

6.  The cholesterol requirement for sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence.

Authors:  Y E Lu; T Cassese; M Kielian
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Furin processing and proteolytic activation of Semliki Forest virus.

Authors:  Xinyong Zhang; Martin Fugère; Robert Day; Margaret Kielian
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Cholesterol-independent targeting of Golgi membrane proteins in insect cells.

Authors:  M M Rolls; M T Marquardt; M Kielian; C E Machamer
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

9.  Differential cholesterol binding by class II fusion proteins determines membrane fusion properties.

Authors:  M Umashankar; Claudia Sánchez-San Martín; Maofu Liao; Brigid Reilly; Alice Guo; Gwen Taylor; Margaret Kielian
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

10.  Differential incorporation of cholesterol by Sindbis virus grown in mammalian or insect cells.

Authors:  Amanda Hafer; Rebecca Whittlesey; Dennis T Brown; Raquel Hernandez
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.